This study is in progress, not accepting new patients
Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE)
Summary
- Eligibility
- for people ages 0 months to 24 months (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Prevail Therapeutics
- ID
- NCT04411654
- Phase
- Phase 1/2 Gaucher Disease Research Study
- Study Type
- Interventional
- Participants
- Expecting 15 study participants
- Last Updated